-

New Clinical and Financial Opportunities for Labs at the Executive War College Conference on Diagnostics, Clinical Laboratory & Pathology Management

AUSTIN, Texas--(BUSINESS WIRE)--Lab executives and pathologists from many of the nation’s most prominent clinical laboratories will come together on April 25-26 to learn about the latest advances in key diagnostic and digital technologies for increasing revenue, lowering costs, and improving patient care at the next Executive War College on Diagnostics, Clinical Laboratory and Pathology Management in New Orleans. The event will feature more than 75 different sessions with up to 125 lab managers, consultants, vendors, and diagnostic experts as speakers.

“With the passing of the pandemic, this is the 'year of opportunity’ for all clinical laboratories and pathology groups,” said Robert Michel, Editor-in-Chief of THE DARK REPORT and founder of the Executive War College. “The best place to learn about how innovative labs are taking advantage of new technologies in their daily operations is this year’s Executive War College.”

“Every lab organization should have their managers and best strategic thinkers attend this year’s Executive War College on April 25-26,” Michel said. “This is the time and place for them to learn from the diagnostic profession’s best innovators and gain insights they’ll need to keep their laboratories at the cutting edge of clinical excellence in a financially sustainable manner.”

Sessions will cover the full range of important new developments in lab management. These include profitably repurposing existing PCR automation, how artificial intelligence is transforming digital pathology and streamlining lab operations; how labs are monetizing lab test data; and how next-gen genome sequencers now allow smaller labs to provide genetic tests and gain substantial revenue from these testing services.

In addition to the comprehensive two-day program, there will be additional post-conference workshops on a third day (for an additional tuition) that will feature a comprehensive tour of genetic testing and the use of genome sequencers in the hospital laboratory, ways to build revenue with digital pathology, and LEAN fundamentals for Lab Managers.

The Executive War College welcomes its 2023 Corporate Benefactors: Beckman Coulter, Change Healthcare, hc1, ELLKAY, Clinisys, Quadax, TELCOR, Wave HDC, Coronis Healthcare, US HealthTek, Thermo Fisher, Synergen Health and XIFIN.

Visit www.executivewarcollege.com for more information, including the comprehensive roster of speakers and sessions and how to register for the event.

About The Dark Report

Established in 1995, The Dark Report is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists, and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces Dark Daily, as well as the renowned Executive War College on Diagnostics, Clinical Laboratory and Pathology Management every spring.

Contacts

Alan Ramsdell
info@darkreport.com

More News From The Dark Report

LabX Media Group Acquires The Dark Intelligence Group Inc, including The Dark Report and the Executive War College

AUSTIN, Texas--(BUSINESS WIRE)--The Dark Intelligence Group (TDIG) announced today that it has sold all its information services assets to LabX Media Group of Midland, Ontario, Canada. This sale involves all TDIG products and services, such as The Dark Report intelligence service, DarkDaily ebriefings, webinars, reports, and events, including the Executive War College on Diagnostic, Laboratory, and Pathology Management, the largest global conference on laboratory management for senior laborator...

Operationalizing FDA LDT Compliance: Expert Panel Reveals Essential Strategies and Actions for Meeting the 1st Reporting Milestone

AUSTIN, Texas--(BUSINESS WIRE)--Many clinical laboratories are now under the gun to achieve Phase One compliance with the Food and Drug Administration’s (FDA) LDT rule before the May 2025 deadline. Labs performing LDTs must take immediate action to protect their most important LDTs that improve patient care while generating substantial reimbursement. This is a high stakes situation for labs offering LDTs because they have only five months to secure their most valuable LDTs. To help labs underst...

Experts to Identify Essential Steps & Pitfalls to Help Clinical Laboratories Meet the Deadline to Comply with the FDA’s Laboratory Developed Test (LDT) Rule

AUSTIN, Texas--(BUSINESS WIRE)--With the first important deadline for compliance with the Food and Drug Administration’s (FDA) LDT rule only eight months away, experts urge clinical laboratories performing LDTs to take immediate action. This is essential to protect their most important LDTs that improve patient care while generating substantial reimbursement. The FDA’s final rule on Laboratory Developed Tests (LDTs) ushers in a radical overhaul of the FDA’s longstanding policy of enforcement di...
Back to Newsroom